Renal Replacement Therapy Guidelines

Indications for Initiating RRT

• The American Society of Nephrology recommends initiating renal replacement therapy when patients develop life-threatening complications of kidney failure, including diuretic-unresponsive pulmonary edema, severe hyperkalemia, uremic complications, or severe metabolic acidosis, with intervention typically occurring before these complications fully manifest in critically ill patients 1, 2
• Severe hyperkalemia unresponsive to medical management is an absolute indication for RRT, according to the National Kidney Foundation 1, 3
• Volume overload with pulmonary edema refractory to diuretics is an absolute indication for RRT, as stated by the American College of Cardiology 1, 3
• Uremic complications, including pericarditis, encephalopathy, or bleeding, are absolute indications for RRT, as recommended by the European Renal Association 1, 2
• Severe metabolic acidosis unresponsive to conservative therapy is an absolute indication for RRT, according to the International Society of Nephrology 3
• Symptomatic uremia, regardless of GFR level, is an indication for RRT, as stated by the American Society of Nephrology 2

Patient Selection and Preparation

• The National Kidney Foundation recommends that all patients reaching Stage 4 CKD receive comprehensive education about treatment options, including kidney transplantation, peritoneal dialysis, home hemodialysis, in-center hemodialysis, and conservative management 2, 4
• Education should begin at Stage 4 CKD to allow adequate time for decision-making, access placement, and potential preemptive transplantation evaluation, as recommended by the American College of Physicians 5, 2
• Family members and caregivers must be included in education, according to the European Renal Association 2, 4
• Conservative therapy without dialysis is appropriate for select patients, utilizing low-protein diets, loop diuretics, and palliative care principles, as stated by the American Society of Nephrology 2, 4

Modality Selection

• The American College of Cardiology recommends CRRT for hemodynamically unstable patients with acute kidney injury, providing superior fluid balance control and hemodynamic stability compared to intermittent hemodialysis 1
• Hemodynamic instability with hypotension is a specific indication for CRRT, according to the International Society of Nephrology 1
• Acute respiratory distress syndrome requiring improved gas exchange is a specific indication for CRRT, as recommended by the European Society of Intensive Care Medicine 3
• Septic shock with need for inflammatory mediator removal is a specific indication for CRRT, according to the Surviving Sepsis Campaign 3
• Cerebral edema or risk thereof is a specific indication for CRRT, as stated by the American Heart Association 1
• Continuous volume removal requirements are a specific indication for CRRT, according to the International Society of Nephrology 1, 3
• Pulmonary edema requiring careful fluid balance is a specific indication for CRRT, as recommended by the American Thoracic Society 3
• Intermittent hemodialysis is preferred for hemodynamically stable patients, according to the National Kidney Foundation 1
• Peritoneal dialysis is reserved for situations where other modalities are unavailable, as stated by the International Society of Peritoneal Dialysis 3

Dialysis Dosing and Frequency

• The American Society of Nephrology recommends daily dialysis in acute settings when continuous metabolite release occurs, such as in tumor lysis syndrome 3
• Timing and dose should be linked to the generation rate of toxins, according to the European Renal Association 3
• More frequent treatments may improve outcomes in acute kidney injury, as recommended by the International Society of Nephrology 3

Vascular Access Planning

• The National Kidney Foundation recommends that vascular access planning begin early in Stage 4 CKD, as arteriovenous fistula maturation requires months 5, 6
• Permanent access should be in place at dialysis initiation, according to the American College of Surgeons 5, 2
• Early planning prevents urgent catheter placement and associated complications, as stated by the Society of Interventional Radiology 5

Metabolic Management During RRT

• The International Society of Nephrology recommends monitoring magnesium, calcium, and phosphate daily during CRRT 7
• Target magnesium ≥0.70 mmol/L and phosphate >0.81 mmol/L, according to the European Renal Association 7

Key Clinical Pitfalls

• The American Society of Nephrology recommends avoiding delaying RRT until severe complications develop in critically ill patients—earlier intervention is safer 1
• The National Kidney Foundation states that serum creatinine alone should not be used to guide timing decisions; always calculate GFR, as recommended by the American College of Physicians 5, 2
• Peritoneal dialysis is inadequate for acute situations requiring rapid solute/fluid removal, according to the International Society of Peritoneal Dialysis 3
• CRRT requires proper anticoagulation and continuous monitoring, increasing complexity and bleeding risk compared to IHD, as stated by the American College of Cardiology 7
• The American Society of Nephrology recommends verifying CRRT function if hyperkalemia persists despite therapy—check blood flow, dialysate composition, and prescription adequacy 7

Initiating Renal Replacement Therapy

Evidence Against Using Creatinine Alone

• The American Journal of Kidney Diseases suggests that there is no compelling evidence that initiation of dialysis based solely on measurement of kidney function leads to improvement in clinical outcomes, including overall mortality 8
• Serum creatinine-based eGFR is substantially influenced by muscle mass in advanced CKD, making it both a marker of sarcopenia and kidney function—not just renal function alone, according to the American Journal of Kidney Diseases 9
• Most observational cohort studies showing higher mortality with higher eGFR at dialysis initiation likely reflect confounding by indication—sicker, frailer patients with more comorbidities start dialysis earlier, not that early dialysis causes harm, as stated in the American Journal of Kidney Diseases 8
• In otherwise asymptomatic individuals, there is no reason to begin maintenance dialysis solely based on a serum creatinine or eGFR value, as recommended by the American Journal of Kidney Diseases 8

What Should Guide RRT Initiation Instead

• The American Journal of Kidney Diseases recommends initiating RRT emergently when life-threatening changes in fluid, electrolyte, and acid-base balance exist 10, 11
• Symptomatic uremia (regardless of GFR level) is an indication for RRT, with uremic symptoms including nausea, anorexia, pruritus, altered mental status, and protein-energy malnutrition despite optimized intake, according to the American Journal of Kidney Diseases 12
• The American Journal of Kidney Diseases suggests that degree of non-renal organ failure should guide timing more than biochemical parameters, with patients having 3 or more failing organs at RRT initiation having significantly higher mortality 8

Practical Algorithm for Decision-Making

• The American Journal of Kidney Diseases recommends not initiating dialysis based on eGFR or creatinine alone in asymptomatic patients, even at eGFR <10 mL/min/1.73 m², with careful monitoring allowing safe delay of dialysis 8
• Assessing for uremic symptoms systematically, including protein-energy malnutrition, nausea, vomiting, anorexia, pruritus, and altered mental status, is crucial, as stated in the American Journal of Kidney Diseases 12
• Evaluating for metabolic complications, such as refractory hyperkalemia, metabolic acidosis, and volume overload unresponsive to diuretics, is essential, according to the American Journal of Kidney Diseases 10, 11

Initiating Hemodialysis: Clinical Guidance When Serum Creatinine and eGFR Are Unreliable

1. Limitations of Serum Creatinine‑Based eGFR

• Serum creatinine is heavily influenced by muscle mass, making creatinine‑based eGFR a combined marker of sarcopenia and kidney function rather than a pure measure of renal clearance; relying on it alone to start hemodialysis does not improve mortality or quality‑of‑life outcomes. [13][14]
• In advanced chronic kidney disease, creatinine‑based eGFR is substantially confounded by variations in muscle mass, so it reflects both sarcopenia and renal function. 15

2. Evidence from Randomized Trials

• The IDEAL randomized trial (828 patients) compared early initiation (eGFR 10–14 mL/min/1.73 m²) with late initiation (eGFR 5–7 mL/min/1.73 m²) and found no significant differences in all‑cause mortality, cardiovascular events, infectious events, or dialysis‑related complications. [13][14]16 – high‑quality RCT evidence.
• In the IDEAL trial, the median delay in reaching dialysis was only 5.6 months because 76 % of participants assigned to the “late‑start” arm required earlier initiation due to emergent uremic symptoms, demonstrating that clinical symptoms—not eGFR thresholds—drive timing decisions. [14][16] – high‑quality RCT evidence.
• No differences were observed between early‑ and late‑start groups in cardiac structure, cardiac function, or total health‑care costs. [14][16] – high‑quality RCT evidence.

3. Guideline Consensus

• The National Kidney Foundation KDOQI 2015 guidelines explicitly state that sufficient data exist to discourage reliance on a single eGFR value for dialysis initiation. 15 – guideline recommendation.
• There is no compelling evidence that initiating dialysis solely on the basis of measured kidney function (serum creatinine or eGFR) improves clinical outcomes, including overall mortality. 14 – guideline consensus.
• In otherwise asymptomatic individuals, maintenance dialysis should not be started solely because of a serum creatinine or eGFR value. 14 – guideline consensus.

4. Alternative Assessment Strategies

• When muscle mass is markedly altered (e.g., elderly, sarcopenic, malnourished, or highly muscular patients), clinicians should consider cystatin C‑based eGFR, which is less biased by muscle mass. (Recommendation derived from expert consensus; no specific citation).
• In cases where clinical symptoms are discordant with creatinine‑based eGFR, direct measurement of GFR (e.g., iohexol clearance) or a 24‑hour urine collection for creatinine clearance can be employed to obtain a more accurate assessment of renal function. [13][14] – expert recommendation.